...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

Buy as much as you can afford!

Zenith may be the ticket to recovering great losses on RVX for many. (IMO)

 

Koo

Share
New Message
Please login to post a reply